Overview

STARLITE for Unresectable High-Grade Gliomas

Status:
RECRUITING
Trial end date:
2030-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed surgically change as a result of the study treatment; and to identify and evaluate the potential side effects (good and bad) of the study treatment in patients with newly diagnosed high-grade glioma(s) that cannot be removed surgically.
Phase:
PHASE1
Details
Lead Sponsor:
University of Miami
Collaborator:
Medtronic
Treatments:
abacavir
Lamivudine
Magnetic Resonance Spectroscopy
Ritonavir
Temozolomide